Prevalence of high-risk human papillomavirus genotypes among women in Uzbekistan, 2021

Prevalence of high-risk human papillomavirus genotypes among women in Uzbekistan, 2021–2023

Published:2025 Issue: Volume:36 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Sharipova Iroda Pulatovna¹^ORCID,Musabaev Erkin Isakovich¹^ORCID,Sadirova Shakhlo Sobirovna¹^ORCID,Suyarkulova Dildora Tolibjonovna¹^ORCID,Tashev Shavkat Ekrinovich¹^ORCID,Akhmedova Shakhnoza Khayrullaevna¹^ORCID,Turabova Nozimakhon Rakhmatullaxodjaevna¹^ORCID,Sharapov Saidkhon Makhmudkhonovich¹^ORCID,Kasimova Rano Ibrahimovna¹^ORCID,Rakhimov Ravshan Abdullaevich¹^ORCID,Yuldashova Guljahon Toyirovna¹^ORCID,Lee Kyutaeg²^ORCID,Chun Gayoung³^ORCID,Kim Hyunwon⁴⁵^ORCID

Affiliation:

1. Research Institute of Virology, Tashkent, Uzbekistan.

2. Department of Laboratory Medicine, GC Labs, Yongin, Korea.

3. Epidemiology & Statistics Team, Infectious Diseases Research Center, GC Labs, Yongin, Korea.

4. Strategy & Planning Unit, GC Labs, Yongin, Korea.

5. Program of Global Health, Department of Public Health, Korea University College of Medicine, Seoul, Korea.

Funder

Korea Foundation for International Healthcare

Publisher

XMLink

Link

https://ejgo.org/pdf/10.3802/jgo.2025.36.e7

Reference19 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

3. The Korean guideline for cervical cancer screening

4. Genital warts and cervical cancer. I. Evidence of an association between subclinical papillomavirus infection and cervical malignancy

5. Opportunities and challenges for human papillomavirus vaccination in cancer